Release of oncofetal fibronectin from human placenta

Placenta

Volumn 24, Issue 8-9, 2003, Pages 843-850

  Guller, S ^a   Ma, Y ^a   Raju, U ^a   Kadner, S ^a   Thung, S F ^a   Colasacco, L ^a   Malek, A ^b   Schneider, H ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; FIBRONECTIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY;

AMNION FLUID; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNODETECTION; MOLECULAR WEIGHT; PATHOPHYSIOLOGY; PLACENTA; PLACENTA DISORDER; PLACENTA PERFUSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECRETION; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING;

EID: 0141503340     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00131-0     Document Type: Article

References (40)

1. 1. Biol Reprod, 60, 828-838.
2. Benirschke K & Kaufmann P (1990) Placental types. In Pathology of the Human Placenta, 2nd edn, pp. 1-12. New York: Springer-Verlag.
3. Bersinger NA, Schneider H & Keller PJ (1986) Synthesis of placental proteins by the human placenta perfused in vitro. Preliminary report. Gynecol Obstet Invest, 22, 47-51.
4. Bersinger NA, Malek A, Benz B, Keller PJ & Schneider H (1988) Effect of protein synthesis and metabolic blockers on the production of placental proteins by the in vitro perfused human placenta. Gynecol Obstet Invest, 25, 145-151.
5. Chavarría ME, Lara-González L, González-Gleason A, Sojo I & Reyes A (2002) Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for the early prediction of preeclampsia. Am J Obstet Gynecol, 187, 595-601.
6. Craven CM, Chedwick LR & Ward K (2002) Placental basal plate formation is associated with fibrin deposition in decidual veins at sites of trophoblast invasion. Am J Obstet Gynecol, 186, 291-296.
7. Damsky CH, Fitzgerald ML & Fisher SJ (1992) Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest, 89, 210-222.
8. Douglas GC & King BF (1989) Isolation of pure villous cytotrophoblast from human term placenta using immunomagnetic microspheres. J Immunol Methods, 119, 259-268.
9. Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ & Cox SM (1992) Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol, 80, 451-454.
10. Feinberg RF, Kliman HJ & Lockwood CJ (1991) Is oncofetal fibronectin a trophoblast glue for implantation? Am J Pathol, 138, 537-543.
11. Feinberg RF & Wang C-L (1994) Monoclonal antibody FDC-6 exhibits binding to human plasma fibronectin: a caveat for cervicovaginal oncofetal fibronectin testing. Am J Obstet Gynecol, 171, 1302-1308.
12. Frank H-G, Huppertz B, Kertschanska S, Blanchard D, Roeleke D & Kaufmann P (1995) Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid. Histochem Cell Biol, 104, 317-329.
13. Ffrench-Constant C, Van de Water L, Dvorak HF & Hynes RO (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol, 109, 903-914.
14. Friedman SA, de Groot CJ, Taylor RN & Roberts JM (1992) Circulating concentrations of fetal fibronectin do not reflect reduced trophoblastic invasion in preeclamptic pregnancies. Am J Obstet Gynecol, 167, 496-497.
15. Friedman SA, de Groot CJM, Taylor RN, Golditch BD & Roberts JM (1994) Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol, 170, 838-841.
16. Gillen-Goldstein J, Ma Y, Lee M-J, Malek A, Schneider H & Guller S (2001) Fetal fibronectin degradation in a placental perfusion model. Abstracts of the Society for Gynecologic Investigation, 2001, 144A.
17. Goldenberg RL, Mercer BM, Meis PJ, Copper RL, Das A & McNellis D (1996) The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol, 87, 643-648.
18. Guller S, Lacroix N, Krikun G, Wozniak R, Markiewicz L, Wang E-Y, Kaplan P & Lockwood CJ (1993) Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts. J Steroid Biochem Molec Biol, 46, 1-10.
19. Guller S, Markiewicz L, Wozniak R, Burnham JM, Wang E-Y, Kaplan P & Lockwood CJ (1994) Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in the human placenta. Endocrinology, 134, 2064-2071.
20. Guller S, Wozniak R, Kong L & Lockwood CJ (1995) Opposing actions of transforming growth factor-β and glucocorticoids in the regulation of fibronectin expression in the human placenta. J Clin Endocrinol Metab, 80, 3273-3278.
21. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H & Kaufmann P (1999) Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest, 79, 1687-1702.
22. Hynes RO (1999) The dynamic dialogue between cells and matrices: implications of fibronectin's elasticity. Proc Natl Acad Sci (USA), 96, 2588-2590.
23. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS & Bissell DM (1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol, 127, 2037-2048.
24. Khandelwal M, Lynch L, Lockwood CJ & Ainbender E (1995) Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester. Am J Perinatol, 12, 161-163.
25. Kliman HJ, Nestler JE, Sermasi E, Sanger JM & Strauss JF III (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
26. Köttgen E, Hell B, Müller C, Kainer F & Tauber R (1989) Developmental changes in the glycosylation and binding properties of human fibronectins. Characterization of the glycan structures and ligand binding of human fibronectins and adult plasma, cord blood and amniotic fluid. Biol Chem Hoppe-Seyler, 370, 1285-1294.
27. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA & Socol ML (1995) Fetal fibronectin levels arc elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol, 172, 649-653.
28. Linnemann K, Malek A, Sager R, Blum WF & Schneider H (2000) Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab, 85, 4298-4301.
29. Lockwood CJ & Peters JH (1990) Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol, 162, 358-362.
30. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones LJ, Deligdisch L & Garite TJ (1991) Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med, 325, 669-674.
31. Matsuura H & Hakomori SI (1985) The oncofetal domain of fibronectin defined by the monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those normal adult tissues and plasma. Proc Natl Acad Sci (USA), 82, 6517-6521.
32. Matsuura H, Takio K, Titani K, Greene T, Levery SB, Salyan MKE & Hakomori SI (1988) The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. J Biol Chem, 263, 3314-3322.
33. Monzon-Bordonaba F, Wang CL & Feinberg RF (1997) Fibronectinase activity in cultured human trophoblasts is mediated by urokinase-type plasminogen activator. Am J Obstet Gynecol, 176, 58-65.
34. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaki ST, Rose J, Chow JC & Strauss JF III (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem, 276, 10220-10233.
35. Runic R, Lockwood CJ, Ma Y, DiPasquale B & Guller S (1996) Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab, 81, 3119-3122.
36. Saito S, Yamaji N, Yasunaga K, Saito T, Matsumoto S, Katoh M, Kobayashi S & Masuho Y (1999) The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem, 274, 30756-30763.
37. Schneider H (1995) Techniques: in vitro perfusion of the human placenta. In Placental Toxicology (Ed.) Sastry BVR, pp. 1-25. Boca Raton: CRC Press.
38. Schwarzbauer JE (1991) Fibronectins: from gene to protein. Curr Opin Cell Biol, 3, 786-791.
39. Ulloa-Aguirre A, August AM, Golos TG, Kao LC, Sakuragi N, Kliman HJ & Strauss JF III (1987) 8-Bromo-adenosine 3′, 5′ -monophosphate regulates expression of chorionic gonadotropin and fibronectin in human cytotrophoblasts. J Clin Endocrinol Metab, 64, 1002-1009.
40. Zhu BC, Fisher SJ, Pande H, Calaycay J, Shively JE & Laine RA (1984) Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen binding domain: difference from human plasma fibronectin. J Biol Chem, 259, 3962-3970.